FDA Adverse Event Malfunction Summary report: N

ACCU-CHEK ® MOBILE TEST STRIPS

MDR report key: 3420427 · Received October 21, 2013

Report

Report Number
1823260-2013-06434
Event Type
Malfunction
Date Received
October 21, 2013
Date of Event
September 10, 2013
Report Date
October 23, 2013
Manufacturer
ROCHE DIAGNOSTICS
Product Code
LFR
PMA / PMN Number
NA
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
UK
Reporter Occupation
MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE

Narratives

Additional Manufacturer Narrative · 1

THE EVENT OCCURRED IN (B)(6). WHILE THIS PRODUCT IS NOT SOLD IN THE UNITED STATES, IT IS LIKE OR SIMILAR TO A PRODUCT MARKETED IN THE UNITED STATES. DEVICE RECEIVED IN A CONDITION WHICH MADE ANALYSIS IMPOSSIBLE. UNABLE TO TEST BECAUSE AN EMPTY VIAL WAS RETURNED.

Additional Manufacturer Narrative · 1

THE EVENT OCCURRED IN (B)(4). WHILE THIS PRODUCT IS NOT SOLD IN THE UNITED STATES, IT IS LIKE OR SIMILAR TO A PRODUCT MARKETED IN THE UNITED STATES. CUSTOMER INDICATED THAT THE CASSETTE WAS DISPOSED OF AND UNAVAILABLE FOR RETURN. DEVICE WILL NOT BE RETURNED.

Description of Event or Problem · 1

CUSTOMER REPORTEDLY RECEIVED THE FOLLOWING RESULTS ON THE MOBILE SYSTEM WITHIN 10 MINUTES: 5.7 MMOL/L, 12.1 MMOL/L, HI (GREATER THAN 33.3 MMOL/L), AND 15.5 MMOL/L. NO ACTIONS TAKEN BASED ON DEVICE RESULTS. NO ADVERSE EVENT REPORTED. REQUESTED RETURN OF SUSPECT DEVICE, HOWEVER THE CUSTOMER RETURNED AM EMPTY TEST CASSETTE.

Description of Event or Problem · 1

CUSTOMER REPORTEDLY RECEIVED THE FOLLOWING RESULTS ON THE MOBILE SYSTEM WITHIN 10 MINUTES: 5.7 MMOL/L, 12.1 MMOL/L, HI (GREATER THAN 33.3 MMOL/L), AND 15.5 MMOL/L. NO ACTIONS TAKEN BASED ON DEVICE RESULTS. NO ADVERSE EVENT REPORTED. REQUESTED RETURN OF SUSPECT DEVICE, HOWEVER, THE CASSETTE HAS BEEN DISPOSED OF AND NOT AVAILABLE FOR RETURN.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
538347 ACCU-CHEK ® MOBILE TEST STRIPS BLOOD GLUCOSE MONITORING TEST STRIPS LFR ROCHE DIAGNOSTICS NA 278251

Patients

Seq Age Sex Outcome Treatment
1 071 YR